Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Connerty

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|May 12, 2026
Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexityJohn N Colgan, Jack H Peplinski, Yi-Cheng Wang, et al.
Cancer Cell|June 20, 2020
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid LeukemiaBasit Salik, Hangyu Yi, Nunki Hassan, et al.
Nature Communications|August 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|May 12, 2026
Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexityJohn N Colgan, Jack H Peplinski, Yi-Cheng Wang, et al.
Cancer Cell|June 20, 2020
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid LeukemiaBasit Salik, Hangyu Yi, Nunki Hassan, et al.
Nature Communications|August 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Pageof 2